comparemela.com

Latest Breaking News On - புதுமையானது தொழில்நுட்பம் விருது - Page 1 : comparemela.com

Morgan Stanley : ValGenesis Inc Secures $24 Million Investment from Morgan Stanley Expansion Capital

American Cell Therapies Company Selects ValGenesis VLMS to Digitize Multiple Validation Lifecycle Processes

American Cell Therapies Company Selects ValGenesis VLMS to Digitize Multiple Validation Lifecycle Processes News provided by Share this article Share this article SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that a U.S. based cell therapies company has selected ValGenesis VLMS – the industry s most trusted electronic validation lifecycle management system – to digitize multiple corporate validation lifecycle processes across the organization. The company develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies. As a fast-growing organization with limited resources, the company is looking to the user-friendly ValGenesis VLMS to help them plan, define, and manage all validation operations, ensuring that the right amount of validation is applied to every system and asset being validated. ValGenesis VLMS will

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.